Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Royalty Pharma plc, dated February 11, 2026 104 Cover Page